Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 7523 | 1279 | 35.6 | 70% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 458 | 15347 | HEMOGLOBIN//SICKLE CELL DISEASE//SICKLE CELL ANEMIA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FETAL HEMOGLOBIN | Author keyword | 58 | 42% | 8% | 108 |
| 2 | HEMOGLOBINOPATHY THALASSEMIA UNIT | Address | 49 | 94% | 1% | 17 |
| 3 | HYDROXYUREA | Author keyword | 26 | 15% | 12% | 159 |
| 4 | GAMMA GLOBIN | Author keyword | 13 | 44% | 2% | 22 |
| 5 | FETAL HEMOGLOBIN HB F | Author keyword | 12 | 75% | 1% | 9 |
| 6 | BCL11A | Author keyword | 11 | 52% | 1% | 15 |
| 7 | DEV PHARMACOL PHARMACOGENOM THER Y THALASS | Address | 10 | 57% | 1% | 12 |
| 8 | F CELLS | Author keyword | 10 | 50% | 1% | 14 |
| 9 | HYDROXYUREA HU | Author keyword | 9 | 48% | 1% | 14 |
| 10 | FETAL HAEMOGLOBIN | Author keyword | 9 | 40% | 1% | 18 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | FETAL HEMOGLOBIN | 58 | 42% | 8% | 108 | Search FETAL+HEMOGLOBIN | Search FETAL+HEMOGLOBIN |
| 2 | HYDROXYUREA | 26 | 15% | 12% | 159 | Search HYDROXYUREA | Search HYDROXYUREA |
| 3 | GAMMA GLOBIN | 13 | 44% | 2% | 22 | Search GAMMA+GLOBIN | Search GAMMA+GLOBIN |
| 4 | FETAL HEMOGLOBIN HB F | 12 | 75% | 1% | 9 | Search FETAL+HEMOGLOBIN+HB+F | Search FETAL+HEMOGLOBIN+HB+F |
| 5 | BCL11A | 11 | 52% | 1% | 15 | Search BCL11A | Search BCL11A |
| 6 | F CELLS | 10 | 50% | 1% | 14 | Search F+CELLS | Search F+CELLS |
| 7 | HYDROXYUREA HU | 9 | 48% | 1% | 14 | Search HYDROXYUREA+HU | Search HYDROXYUREA+HU |
| 8 | FETAL HAEMOGLOBIN | 9 | 40% | 1% | 18 | Search FETAL+HAEMOGLOBIN | Search FETAL+HAEMOGLOBIN |
| 9 | HBF INDUCTION | 8 | 70% | 1% | 7 | Search HBF+INDUCTION | Search HBF+INDUCTION |
| 10 | BETA HEMOGLOBINOPATHIES | 6 | 71% | 0% | 5 | Search BETA+HEMOGLOBINOPATHIES | Search BETA+HEMOGLOBINOPATHIES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FETAL HEMOGLOBIN | 57 | 23% | 17% | 220 |
| 2 | F PRODUCTION | 56 | 89% | 2% | 25 |
| 3 | FETAL HEMOGLOBIN PRODUCTION | 50 | 47% | 6% | 79 |
| 4 | ADULT ERYTHROID CELLS | 49 | 78% | 3% | 32 |
| 5 | GLOBIN GENE EXPRESSION | 44 | 35% | 8% | 101 |
| 6 | HBS1L MYB | 42 | 83% | 2% | 24 |
| 7 | FETAL HEMOGLOBIN INDUCTION | 42 | 76% | 2% | 29 |
| 8 | HUG KIDS | 42 | 94% | 1% | 15 |
| 9 | BCL11A | 40 | 59% | 3% | 44 |
| 10 | GAMMA GLOBIN | 30 | 33% | 6% | 76 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Clinical experience with fetal hemoglobin induction therapy in patients with beta-thalassemia | 2013 | 15 | 105 | 80% |
| Fetal hemoglobin in sickle cell anemia | 2011 | 51 | 77 | 58% |
| Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in children | 2012 | 23 | 34 | 59% |
| Reawakening fetal hemoglobin: prospects for new therapies for the beta-globin disorders | 2012 | 30 | 112 | 44% |
| How I use hydroxyurea to treat young patients with sickle cell anemia | 2010 | 64 | 88 | 60% |
| Anemia: progress in molecular mechanisms and therapies | 2015 | 2 | 110 | 23% |
| Control of fetal hemoglobin: new insights emerging from genomics and clinical implications | 2009 | 70 | 52 | 38% |
| The role of hydroxyurea in sickle cell disease | 2003 | 65 | 68 | 71% |
| Fetal Globin Gene Repressors as Drug Targets for Molecular Therapies To Treat the beta-Globinopathies | 2014 | 8 | 120 | 31% |
| Update on fetal hemoglobin gene regulation in hemoglobinopathies | 2011 | 33 | 89 | 46% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HEMOGLOBINOPATHY THALASSEMIA UNIT | 49 | 94% | 1.3% | 17 |
| 2 | DEV PHARMACOL PHARMACOGENOM THER Y THALASS | 10 | 57% | 0.9% | 12 |
| 3 | MOL MED BRANCH | 3 | 17% | 1.3% | 17 |
| 4 | TOHOKU MED MEGABANK | 3 | 45% | 0.4% | 5 |
| 5 | MOL GENOM THER EUT SECT | 3 | 60% | 0.2% | 3 |
| 6 | EXCELLENCE SICKLE CELL DIS | 2 | 24% | 0.6% | 8 |
| 7 | ANIM SCI MOL BIOL | 2 | 67% | 0.2% | 2 |
| 8 | EMGO NCA | 2 | 67% | 0.2% | 2 |
| 9 | HEMATOL ONCOL EXCELLENCE SICKLE CELL DIS | 2 | 67% | 0.2% | 2 |
| 10 | TWIN EPIDEMIOL UNIT | 2 | 67% | 0.2% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000215658 | LOCUS CONTROL REGION//HEMOGLOBIN SWITCHING//EKLF |
| 2 | 0.0000176667 | HYDROXYUREA//GENET HUMAN THER Y//TARGET CELL AVAILABILITY |
| 3 | 0.0000156590 | SICKLE CELL DISEASE//ACUTE CHEST SYNDROME//SICKLE CELL ANEMIA |
| 4 | 0.0000142695 | INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN//MEDITERRANEAN HEMATOL//TR IANTO MIDOLLO OSSEO MURAGLIA |
| 5 | 0.0000139275 | DEV MODEL//PROTEIN WORD//DEV |
| 6 | 0.0000112019 | AHSP//ALPHA HEMOGLOBIN STABILIZING PROTEIN AHSP//ALPHA HEMOGLOBIN STABILIZING PROTEIN |
| 7 | 0.0000110042 | HEMOGLOBIN//ALPHA THALASSEMIA//BETA THALASSEMIA |
| 8 | 0.0000106969 | SICKLE CELL NEPHROPATHY//SICKLE NEPHROPATHY//REFERENCE SYNDROMES DREPANOCYTAI MAJEURS |
| 9 | 0.0000104217 | SICKLE CELL DISEASE//PEDIATRIC SICKLE CELL DISEASE//SICKLE CELL PAIN |
| 10 | 0.0000093962 | NUTR GROWTH//PROPHYLACTIC TRANSFUSION//NUCLEO ACOES PESQUISA OIO DIAGNOST NUPAD |